Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tilray
AddedFeb 20, 2024
UpdatedJun 28, 2026
Tilray

Tilray

Public

Global cannabis and hemp company specializing in research, cultivation, and distribution.

HQ
Nanaimo, British Columbia, CA
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Tilray Brands, Inc., founded in 2013 by Brendan Kennedy, is a global cannabis and hemp company headquartered in New York City. The company specializes in the research, cultivation, processing, and distribution of cannabis and hemp products, including whole flower, oils, and extracts. Tilray's core mission is to provide high-quality cannabis products to patients, physicians, pharmacies, hospitals, governments, and researchers worldwide. Their market focus spans both medical and recreational cannabis sectors, aiming to improve patient care and expand access to cannabis-based treatments.

Notable figures associated with Tilray include CEO Irwin D. Simon. The company is publicly traded on both Nasdaq and TSX under the ticker symbol TLRY. Tilray has achieved significant milestones, such as generating $627 million in revenue in 2023 and employing around 1,600 people. Its impact is evident in its broad market reach and contributions to cannabis research and development. Through strategic partnerships and a commitment to innovation, Tilray has positioned itself as a leader in the global cannabis industry.

Tilray - Similar Companies

Canopy Growth logo

Canopy Growth

canopygrowth.com

MedMen logo

MedMen

Aurora Cannabis logo

Aurora Cannabis

auroramj.com

CuraleafHoldnc. logo

CuraleafHoldnc.

curaleaf.com

Marijuana Company of America logo

Marijuana Company of America

Cresco Labs logo

Cresco Labs

crescolabs.com

Medical Marijuana logo

Medical Marijuana

Jushi Holdings logo

Jushi Holdings

jushico.com

TerrAscend logo

TerrAscend

terrascend.com

PharmaCann logo

PharmaCann

pharmacann.com

Dogecoin Cash logo

Dogecoin Cash

cbds.com

DNA Genetics logo

DNA Genetics

dnagenetics.com

The Cannabist Company logo

The Cannabist Company

columbia.care

Cannabis Strategic Ventures logo

Cannabis Strategic Ventures

American Cannabis Company logo

American Cannabis Company

Tilray - Quick Facts

Who are Tilray's competitors?

Companies similar to Tilray include Canopy Growth, MedMen, Aurora Cannabis and CuraleafHoldnc..

When was Tilray founded?

Tilray was founded in 2013.

Where is Tilray's headquarters located?

Tilray's headquarters is located in Nanaimo, British Columbia, CA.

When was Tilray's last funding round?

Tilray's most recent funding round was for $150M (USD) in May 2023.

How much has Tilray raised to-date?

As of May 26, 2023, Tilray has raised a total of $660.9M (USD).

How many employees does Tilray have?

Tilray has 1,600 employees as of Feb 12, 2024.

Tilray - Classification

Ownership
  • Public
Technology
  • Agriculture
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Cannabis
Tags
  • Cannabis
Unique IDs
  • ein: 824310622
  • secCik: 0001731348
  • ticker: TLRY
NAICS
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 11 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325411Medicinal and Botanical Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2833Medicinal Chemicals And Botanical Products
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations